Adrian Hugenmatter, PhD
Login to view DISC.Dr. Adrian Hugenmatter directs Protein Engineering at Stanfords Sarafan ChEM-H and leads Protein Therapeutics at the Innovative Medicines Accelerator. With a PhD from ETH Zürich and industry experience at Roche, he is a self-described "drug hunter" focused on creating novel protein-based medicines that combine high therapeutic efficacy with maximum safety.
He is an entrepreneur in the biotech space, having co-founded Spire Biotechnology. His work is driven by a passion for realizing new, innovative solutions in drug research through clever protein engineering and interdisciplinary collaboration.
Unique fact: He holds a certification in "Business Creation BIOTECH, " underscoring his interest in the commercialization of scientific discoveries.
Read the full overview →How Adrian shows up
Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Topics Adrian cares about
Work history
Media appearances
DISC profile (public)
DISC behavioral profile
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Other Stanford University Employees
Explore more public profiles from related professionals.
More profiles
Discover additional public profiles from our index.
Search more profiles
Looking for someone else? Search here for anyone.